The asymmetric unit of the title compound, C9H7NO2S, contains two crystallographically independent molecules (A and B). Both molecules are almost planar [maximum deviations = 0.047 (1) and 0.090 (1) Å, respectively, for the S atoms] with the oxazole and thiophene rings being inclined to one another by 2.65 (16) in molecule A and by 4.55 (15) in molecule B. In the crystal, the individual molecules are linked via C—H O hydrogen bonds, forming –A–B–A–B – chains along the [101] direction. The chains are linked via C—H and – interactions [intercentroid distances = 3.767 (2) and 3.867 (2) Å] involving inversion-related oxazole and thio-phene rings in both molecules, forming a three-dimensional structure
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C18H20N4O2S2, is a new 1,3,4-oxadiazole and a key pharmacophore of several biolo...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The title compound, C9H8N2O2S3, crystallizes with two molecules (A and B) in the asymmetric unit. Bo...
R factor = 0.054; wR factor = 0.133; data-to-parameter ratio = 17.0. The asymmetric unit of the titl...
The title compound, C9H8N2O2S3, crystallizes with two mol-ecules (A and B) in the asymmetric unit. B...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title 1,3,4-oxadiazole-2-thione derivative, C18H20N4OS2, crystallized with two independent molec...
The asymmetric unit of the title compound, C17H13N5O, comprises four independent molecules (A–D). Th...
The title 1,3,4-oxadiazole-2-thione derivative, C18H20N4OS2, crystallized with two independent molec...
The asymmetric unit of the title compound, C8H8N4S2, contains two crystallographically independent m...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C18H20N4O2S2, is a new 1,3,4-oxadiazole and a key pharmacophore of several biolo...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The asymmetric unit of the title compound, C18H11NO2S, contains two crystallographically independent...
The title compound, C9H8N2O2S3, crystallizes with two molecules (A and B) in the asymmetric unit. Bo...
R factor = 0.054; wR factor = 0.133; data-to-parameter ratio = 17.0. The asymmetric unit of the titl...
The title compound, C9H8N2O2S3, crystallizes with two mol-ecules (A and B) in the asymmetric unit. B...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title 1,3,4-oxadiazole-2-thione derivative, C18H20N4OS2, crystallized with two independent molec...
The asymmetric unit of the title compound, C17H13N5O, comprises four independent molecules (A–D). Th...
The title 1,3,4-oxadiazole-2-thione derivative, C18H20N4OS2, crystallized with two independent molec...
The asymmetric unit of the title compound, C8H8N4S2, contains two crystallographically independent m...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C11H10N2O4S, crystallized with two independent molecules (A and B) in the asymme...
The title compound, C18H20N4O2S2, is a new 1,3,4-oxadiazole and a key pharmacophore of several biolo...